146 related articles for article (PubMed ID: 3031263)
1. Synergistic anticellular and antiviral activities of human recombinant interferon-gamma and -beta.
Gomi K; Kimura H; Okabe M; Oka T; Morimoto M
J Pharmacobiodyn; 1986 Nov; 9(11):871-8. PubMed ID: 3031263
[TBL] [Abstract][Full Text] [Related]
2. Different kinetics of antiviral and anticellular activities between human recombinant and natural interferon-gamma arising from different receptor-binding properties.
Gomi K; Akinaga S; Inoue A; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1986 Sep; 77(9):946-55. PubMed ID: 3095289
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of antiviral and anticellular activities of human recombinant interferon-gamma.
Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Mar; 76(3):224-34. PubMed ID: 3922841
[TBL] [Abstract][Full Text] [Related]
4. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
Gomi K; Akinaga S; Oka T; Morimoto M
Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of human recombinant interferon-gamma and -beta against human osteosarcoma transplanted into nude mice.
Gomi K; Oka T; Morimoto M
J Pharmacobiodyn; 1986 Nov; 9(11):879-88. PubMed ID: 3104572
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of the antiviral and anticellular activities of interferons by mixtures of HuIFN-gamma and HuIFN-alpha or HuIFN-beta.
Oleszak E; Stewart WE
J Interferon Res; 1985; 5(2):361-71. PubMed ID: 2989390
[TBL] [Abstract][Full Text] [Related]
7. Possible involvement of virus-induced protein kinase in the antiviral state induced with interferon-gamma against Sindbis virus.
Saito S
J Interferon Res; 1989 Feb; 9(1):23-34. PubMed ID: 2541209
[TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of human recombinant interferon-beta against human melanomas transplanted into nude mice.
Gomi K; Morimoto M; Nakamizo N
J Pharmacobiodyn; 1984 Dec; 7(12):951-61. PubMed ID: 6533284
[TBL] [Abstract][Full Text] [Related]
9. The different effects of recombinant human interferon-gamma and recombinant human interferon-beta on the activation of natural killer cells.
Okabe M; Gomi K; Morimoto M; Nakamizo N
Jpn J Cancer Res; 1985 Jul; 76(7):608-17. PubMed ID: 3928557
[TBL] [Abstract][Full Text] [Related]
10. Growth-inhibitory activity of recombinant human interferon-beta against cultured human cells.
Gomi K; Morimoto M; Nakamizo N
Gan; 1983 Oct; 74(5):737-42. PubMed ID: 6642144
[TBL] [Abstract][Full Text] [Related]
11. Regulation of macrophage growth and antiviral activity by interferon-gamma.
Goldberg M; Belkowski LS; Bloom BR
J Cell Biol; 1989 Sep; 109(3):1331-40. PubMed ID: 2549078
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of different leukemic cell lines to the anticellular and antiviral effects of interferons.
Ho CK; Chen HY; Perng RJ; Lai JL
Proc Natl Sci Counc Repub China B; 1985 Jul; 9(3):235-8. PubMed ID: 2999858
[TBL] [Abstract][Full Text] [Related]
13. Requirement for IFN gamma in potentiation of interferon's antiviral and anticellular activities: identity of mouse and human systems.
Fleischmann WR; Schwarz LA; Fleischmann CM
J Interferon Res; 1984; 4(2):265-74. PubMed ID: 6431021
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Epstein-Barr virus infection in vitro by recombinant human interferons alpha and gamma.
Kure S; Tada K; Wada J; Yoshie O
Virus Res; 1986 Sep; 5(4):377-90. PubMed ID: 3022498
[TBL] [Abstract][Full Text] [Related]
15. Potentiating effect of murine interferon-gamma-containing lymphokine preparations on the antiviral and antiproliferative effects of murine interferon-alpha/beta: identification of the potentiation factor as murine interferon-gamma itself.
Fleischmann WR; Fleischmann CM
Antiviral Res; 1984 Aug; 4(4):221-8. PubMed ID: 6091541
[TBL] [Abstract][Full Text] [Related]
16. Antiviral effect of recombinant equine interferon-gamma on several equine viruses.
Sentsui H; Wu D; Murakami K; Kondo T; Matsumura T
Vet Immunol Immunopathol; 2010 May; 135(1-2):93-99. PubMed ID: 20004981
[TBL] [Abstract][Full Text] [Related]
17. Absence of antiviral activity in recombinant B cell stimulatory factor 2 (BSF-2).
Hirano T; Matsuda T; Hosoi K; Okano A; Matsui H; Kishimoto T
Immunol Lett; 1988 Jan; 17(1):41-5. PubMed ID: 2832321
[TBL] [Abstract][Full Text] [Related]
18. Effects of combinations of interferon-beta ser and interferon-gamma on interferon-inducible proteins and on the cell cycle.
Schiller JH; Horisberger MA; Bittner G; Carlin JM; Storer B; Byrne GI; Willson JK; Borden EC
J Biol Response Mod; 1990 Aug; 9(4):368-77. PubMed ID: 2395002
[TBL] [Abstract][Full Text] [Related]
19. Virus-specific effects of recombinant porcine interferon-gamma and the induction of Mx proteins in pig cells.
Horisberger MA
J Interferon Res; 1992 Dec; 12(6):439-44. PubMed ID: 1337754
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor-alpha, interferon-gamma and interferon-beta exert antiviral activity in nervous tissue cells.
Schijns VE; Van der Neut R; Haagmans BL; Bar DR; Schellekens H; Horzinek MC
J Gen Virol; 1991 Apr; 72 ( Pt 4)():809-15. PubMed ID: 1849968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
